glp-1 weight loss schererville Struggling with loss? You're not alone — and we can help. 🙌, Our new GLP-1–based weight program offers medical guidance, weekly monitoring, and a customized plan built around YOU., ✨ Weight Loss Programs Tailored for

Description

2016: The FDA New Drug Application is filed

Recent Studies Linking Ozempic to Gastroparesis April 2025: A study called Comparing the risk of gastroparesis following different modalities for treating obesity: semaglutide versus bupropion-naltrexone versus sleeve gastrectomy a retrospective cohort study examined if people taking GLP-1 drugs like Ozempic had a higher risk of gastroparesis than people taking another weight-loss drug called bupropion-naltrexone and a treatment called a sleeve gastrectomy

What are the risks of using GLP-1 (Glucagon-like peptide-1) receptor agonists, such as liraglutide (Victoza) or semaglutide (Ozempic), in a patient with decompensated cirrhosis and a history of multiple thyroid nodules, and why are they avoided at this stage?

Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1c targets